Spotlight
Workshop: Defining the Standard of Care: FDA-Cleared, Clinically Proven CML Monitoring at the MR 4.7 Level
Wednesday, November 9 from 12:00-12:45 pm
Defining the Standard of Care: FDA-Cleared, Clinically Proven CML Monitoring at the MR 4.7 Level, presented by Christopher D. Watt, M.D., Ph.D. and Bernard F. Andruss, Ph.D.